Activity and intracellular location of estrogen receptors α and β in human bronchial epithelial cells

Molecular and Cellular Endocrinology

Volumn 305, Issue 1-2, 2009, Pages 12-21

  Ivanova, Margarita M ^a   Mazhawidza, Williard ^a   Dougherty, Susan M ^a   Minna, John D ^b   Klinge, Carolyn M ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cyclin D1; Estrogen receptor; Lung adenocarcinoma (human); Normal lung (human); SMRT

Indexed keywords

4 HYDROXYTAMOXIFEN; CYCLIN D1; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; LUCIFERASE;

ADULT; AGED; ARTICLE; CARCINOMA CELL; CELL NUCLEUS; CELL PROLIFERATION; CELL SPECIFICITY; CELLULAR DISTRIBUTION; CYTOPLASM; EPITHELIUM CELL; ESTROGEN RESPONSIVE ELEMENT; FEMALE; GENDER; HUMAN; HUMAN CELL; LUNG CARCINOGENESIS; MALE; MITOCHONDRION; PRIORITY JOURNAL; TRANSCRIPTION INITIATION;

ADENOCARCINOMA; BRONCHI; CELL NUCLEUS; CELLS, CULTURED; CYTOPLASM; EPITHELIAL CELLS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; HYDROXYTESTOSTERONES; LUNG NEOPLASMS; MALE; MITOCHONDRIA; SEX FACTORS;

EID: 67349246260     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2009.01.021     Document Type: Article

References (76)

1. Almqvist C., Worm M., and Leynaert B. Impact of gender on asthma in childhood and adolescence: a ga2len review. Allergy 63 (2008) 47-57
2. Altucci L., Addeo R., Cicatiello L., Dauvois S., Parker M.G., Truss M., Beato M., Sica V., Bresciani F., and Weisz A. 17beta-estradiol induces cyclin d1 gene transcription, p36d1-p34cdk4 complex activation and p105rb phosphorylation during mitogenic stimulation of g(1)-arrested human breast cancer cells. Oncogene 12 (1996) 2315-2324
3. Barr R.G., Wentowski C.C., Grodstein F., Somers S.C., Stampfer M.J., Schwartz J., Speizer F.E., and Camargo Jr. C.A. Prospective study of postmenopausal hormone use and newly diagnosed asthma and chronic obstructive pulmonary disease. Arch. Intern. Med. 164 (2004) 379-386
4. Bustin S.A. Quantification of mrna using real-time reverse transcription pcr (rt-pcr): trends and problems. J. Mol. Endocrinol. 29 (2002) 23-39
5. Cammarata P.R., Chu S., Moor A., Wang Z., Yang S.-H., and Simpkins J.W. Subcellular distribution of native estrogen receptor [alpha] and [beta] subtypes in cultured human lens epithelial cells. Exp. Eye Res. 78 (2004) 861-871
6. Carey M.A., Card J.W., Voltz J.W., Arbes Jr. S.J., Germolec D.R., Korach K.S., and Zeldin D.C. It's all about sex: gender, lung development and lung disease. Trend Endocrinol. Metab. 18 (2007) 308-313
7. Carey M.A., Card J.W., Voltz J.W., Germolec D.R., Korach K.S., and Zeldin D.C. The impact of sex and sex hormones on lung physiology and disease: lessons from animal studies. Am. J. Physiol. Lung Cell. Mol. Physiol. 293 (2007) L272-L278
8. Chang L.W., Chang Y.-C., Ho C.-C., Tsai M.-H., and Lin P. Increase of carcinogenic risk via enhancement of cyclooxygenase-2 expression and hydroxyestradiol accumulation in human lung cells as a result of interaction between bap and 17-beta estradiol. Carcinogenesis 28 (2007) 1606-1612
9. Chen J.-Q., Russo P.A., Cooke C., Russo I.H., and Russo J. Er[beta] shifts from mitochondria to nucleus during estrogen-induced neoplastic transformation of human breast epithelial cells and is involved in estrogen-induced synthesis of mitochondrial respiratory chain proteins. Biochim. Biophys. Acta (BBA)-Mol. Cell Res. 1773 (2007) 1732-1746
10. Chen J.D., and Evans R.M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377 (1995) 454-457
11. Chen J.Q., Delannoy M., Cooke C., and Yager J.D. Mitochondrial localization of eralpha and erbeta in human mcf7 cells. Am. J. Physiol. Endocrinol. Metab. 286 (2004) E1011-E1022
12. Cho E.Y., Choi Y.-L., Han J.J., Kim K.-M., and Oh Y.L. Expression and amplification of her2, egfr and cyclin d1 in breast cancer: immunohistochemistry and chromogenic in situ hybridization. Pathol. Int. 58 (2008) 17-25
13. Couse J.F., Lindzey J., Grandien K., Gustafsson J.A., and Korach K.S. Tissue distribution and quantitative analysis of estrogen receptor-alpha (eralpha) and estrogen receptor-beta (erbeta) messenger ribonucleic acid in the wild-type and eralpha-knockout mouse. Endocrinology 138 (1997) 4613-4621
14. Dougherty S.M., Mazhawidza W., Bohn A.R., Robinson K.A., Mattingly K.A., Blankenship K.A., Huff M.O., McGregor W.G., and Klinge C.M. Gender difference in the activity but not expression of estrogen receptors alpha and beta in human lung adenocarcinoma cells. Endocr.-Relat. Cancer 13 (2006) 113-134
15. Eeckhoute J., Carroll J.S., Geistlinger T.R., Torres-Arzayus M.I., and Brown M. A cell-type-specific transcriptional network required for estrogen regulation of cyclin d1 and cell cycle progression in breast cancer. Genes Dev. 20 (2006) 2513-2526
16. Flouriot G., Brand H., Denger S., Metivier R., Kos M., Reid G., Sonntag-Buck V., and Gannon F. Identification of a new isoform of the human estrogen receptor-alpha (her-alpha) that is encoded by distinct transcripts and that is able to repress her-alpha activation function 1. EMBO J. 19 (2000) 4688-4700
17. Gautschi O., Ratschiller D., Gugger M., Betticher D.C., and Heighway J. Cyclin d1 in non-small cell lung cancer: a key driver of malignant transformation. Lung Cancer 55 (2007) 1-14
18. Ginzinger D.G. Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp. Hematol. 30 (2002) 503-512
19. González-Arenas A., Neri-Gómez T., Guerra-Araiza C., and Camacho-Arroyo I. Sexual dimorphism in the content of progesterone and estrogen receptors, and their cofactors in the lung of adult rats. Steroids 69 (2004) 351-356
20. Gopalakrishnan L., and Scarpulla R.C. Structure, expression, and chromosomal assignment of the human gene encoding nuclear respiratory factor 1. J. Biol. Chem. 270 (1995) 18019-18025
21. Hall J.M., and McDonnell D.P. The estrogen receptor beta-isoform (erbeta) of the human estrogen receptor modulates eralpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 140 (1999) 5566-5578
22. Hammoud Z., Tan B., Badve S., and Bigsby R.M. Estrogen promotes tumor progression in a genetically defined mouse model of lung adenocarcinoma. Endocr. Relat. Cancer 15 (2008) 475-483
23. Han M.K., Postma D., Mannino D.M., Giardino N.D., Buist S., Curtis J.L., and Martinez F.J. Gender and chronic obstructive pulmonary disease: why it matters. Am. J. Respir. Crit. Care Med. 176 (2007) 1179-1184
24. Han W., Pentecost B., Pietropaolo R., Fasco M., and Spivack S.D. Estrogen receptor a increases basal and cigarette smoke extract-induced expression of cyp1a1and cyp1b1, but not gstp1, in normal human bronchial epithelial cells. Mol. Carcinog. 44 (2005) 202-211
25. Hershberger P.A., Vasquez A.C., Kanterewicz B., Land S., Siegfried J.M., and Nichols M. Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands. Cancer Res. 65 (2005) 1598-1605
26. Hong J., Shah N.N., Thomas T.J., Gallo M.A., Yurkow E.J., and Thomas T. Differential effects of estradiol and its analogs on cyclin d1 and cdk4 expression in estrogen receptor positive mcf-7 and estrogen receptor-transfected mcf-10aewt5 cells. Oncol. Rep. 5 (1998) 1025-1033
27. Ishibashi H., Suzuki T., Suzuki S., Niikawa H., Lu L., Miki Y., Moriya T., Hayashi S.-i., Handa M., Kondo T., and Sasano H. Progesterone receptor in non-small cell lung cancer-a potent prognostic factor and possible target for endocrine therapy. Cancer Res. 65 (2005) 6450-6458
28. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics. CA Cancer J. Clin. 57 (2007) 43-66
29. Jonsson D., Nilsson J., Odenlund M., Bratthall G., Broman J., Ekblad E., Lydrup M.-L., and Nilsson B.-O. Demonstration of mitochondrial oestrogen receptor [beta] and oestrogen-induced attenuation of cytochrome c oxidase subunit i expression in human periodontal ligament cells. Arch. Oral Biol. 52 (2007) 669-676
30. Klinge C.M. Estrogen receptor interaction with co-activators and co-repressors. Steroids 65 (2000) 227-251
31. Klinge C.M., Jernigan S.C., Mattingly K.A., Risinger K.E., and Zhang J. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors. J. Mol. Endocrinol. 33 (2004) 387-410
32. Kuiper G.G., Carlsson B., Grandien J., Enmark E., Haggblad J., Nilsson S., and Gustafsson J.-A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138 (1997) 863-870
33. Kulakosky P.C., Jernigan S.C., McCarty M.A., and Klinge C.M. Response element sequence regulates estrogen receptor alpha and beta affinity and activity. J. Mol. Endocrinol. 29 (2002) 137-152
34. Lim R.H., and Kobzik L. Sexual tension in the airways: the puzzling duality of estrogen in asthma. Am. J. Respir. Cell Mol. Biol. 38 (2008) 499-500
35. MacGregor J.I., and Jordan V.C. Basic guide to the mechanisms of antiestrogen action. Pharmacol. Rev. 50 (1998) 151-196
36. Machado M.-C.L. Gender and prognosis of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 177 (2008) 928
37. Machado M.-C.L., Krishnan J.A., Buist S.A., Bilderback A.L., Fazolo G.P., Santarosa M.G., Queiroga Jr. F., and Vollmer W.M. Sex differences in survival of oxygen-dependent patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 174 (2006) 524-529
38. Marquez-Garban D.C., Chen H.-W., Fishbein M.C., Goodglick L., and Pietras R.J. Estrogen receptor signaling pathways in human non-small cell lung cancer. Steroids 72 (2007) 135-143
39. Massaro D., Clerch L.B., and Massaro G.D. Estrogen receptor-{alpha} regulates pulmonary alveolar loss and regeneration in female mice: morphometric and gene expression studies. Am. J. Physiol. Lung Cell. Mol. Physiol. 293 (2007) L222-228
40. Massaro D., and DeCarlo Massaro G. Developmental alveologenesis: longer, differential regulation and perhaps more danger. Am. J. Physiol. Lung Cell Mol. Physiol. 293 (2007) L568-569
41. Massaro D., and Massaro G.D. Estrogen regulates pulmonary alveolar formation, loss, and regeneration in mice. Am. J. Physiol. Lung Cell Mol. Physiol. 287 (2004) L1154-1159
42. Massaro D., and Massaro G.D. Estrogen receptor regulation of pulmonary alveolar dimensions: alveolar sexual dimorphism in mice. Am. J. Physiol. Lung Cell Mol. Physiol. 290 (2006) L866-870
43. Matsubara S., Swasey C.H., Loader J.E., Dakhama A., Joetham A., Ohnishi H., Balhorn A., Miyahara N., Takeda K., and Gelfand E.W. Estrogen determines sex differences in airway responsiveness after allergen exposure. Am. J. Respir. Cell Mol. Biol. 38 (2008) 501-508
44. Mattingly K.A., Ivanova M.M., Riggs K.A., Wickramasinghe N.S., Barch M.J., and Klinge C.M. Estradiol stimulates transcription of nuclear respiratory factor-1 and increases mitochondrial biogenesis. Mol. Endocrinol. 22 (2008) 609-622
45. McDonnell D.P., Clemm D.L., Hermann T., Goldman M.E., and Pike J.W. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol. Endocrinol. 9 (1995) 659-669
46. Merot Y., Metivier R., Penot G., Manu D., Saligaut C., Gannon F., Pakdel F., Kah O., and Flouriot G. The relative contribution exerted by af-1 and af-2 transactivation functions in estrogen receptor {alpha} transcriptional activity depends upon the differentiation stage of the cell. J. Biol. Chem. 279 (2004) 26184-26191
47. Metivier R., Gay F.A., Hubner M.R., Flouriot G., Salbert G., Gannon F., Kah O., and Pakdel F. Formation of an her alpha-coup-tfi complex enhances her alpha af-1 through ser118 phosphorylation by mapk. EMBO J. 21 (2002) 3443-3453
48. Metivier R., Stark A., Flouriot G., Hubner M.R., Brand H., Penot G., Manu D., Denger S., Reid G., Kos M., Russell R.B., Kah O., Pakdel F., and Gannon F. A dynamic structural model for estrogen receptor-alpha activation by ligands, emphasizing the role of interactions between distant a and e domains. Mol. Cell 10 (2002) 1019-1032
49. Mollerup S., Jorgensen K., Berge G., and Haugen A. Expression of estrogen receptors alpha and beta in human lung tissue and cell lines. Lung Cancer 37 (2002) 153-159
50. Monje P., and Boland R. Subcellular distribution of native estrogen receptor alpha and beta isoforms in rabbit uterus and ovary. J. Cell Biochem. 82 (2001) 467-479
51. Morani A., Barros R.P.A., Imamov O., Hultenby K., Arner A., Warner M., and Gustafsson J.-A. Lung dysfunction causes systemic hypoxia in estrogen receptor beta knockout (erbeta-/-) mice. PNAS 103 (2006) 7165-7169
52. Nagy L., Kao H.-Y., Chakravarti D., Lin R.J., Hassig C.A., Ayer D.E., Schreiber S.L., and Evans R.M. Nuclear receptor repression mediated by a complex containing smrt, msin3a, and histone deacetylase. Cell 89 (1997) 373-380
53. Niikawa H., Suzuki T., Miki Y., Suzuki S., Nagasaki S., Akahira J., Honma S., Evans D.B., Hayashi S.-i., Kondo T., and Sasano H. Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma. Clin. Cancer Res. 14 (2008) 4417-4426
54. O'Malley B.W., and McKenna N.J. Editorial: coactivators and corepressors: what's in a name?. Mol. Endocrinol. 22 (2008) 2213-2214
55. Ordentlich P., Downes M., Xie W., Genin A., Spinner N.B., and Evans R.M. Unique forms of human and mouse nuclear receptor corepressor smrt. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 2639-2644
56. Patrone C., Cassel T.N., Pettersson K., Piao Y.-S., Cheng G., Ciana P., Maggi A., Warner M., Gustafsson J.-A., and Nord M. Regulation of postnatal lung development and homeostasis by estrogen receptor {beta}. Mol. Cell. Biol. 23 (2003) 8542-8552
57. Pedram A., Razandi M., Wallace D.C., and Levin E.R. Functional estrogen receptors in the mitochondria of breast cancer cells. Mol. Biol. Cell 17 (2006) 2125-2137
58. Penot G., Le Peron C., Merot Y., Grimaud-Fanouillere E., Ferriere F., Boujrad N., Kah O., Saligaut C., Ducouret B., Metivier R., and Flouriot G. The human estrogen receptor-{alpha} isoform her{alpha}46 antagonizes the proliferative influence of her{alpha}66 in mcf7 breast cancer cells. Endocrinology 146 (2005) 5474-5484
59. Peterson T.J., Karmakar S., Pace M.C., Gao T., and Smith C.L. The silencing mediator of retinoic acid and thyroid hormone receptor (smrt) corepressor is required for full estrogen receptor {alpha} transcriptional activity. Mol. Cell. Biol. 27 (2007) 5933-5948
60. Pietras R.J., Marquez D.C., Chen H.W., Tsai E., Weinberg O., and Fishbein M. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells. Steroids 70 (2005) 372-381
61. Ramirez R.D., Sheridan S., Girard L., Sato M., Kim Y., Pollack J., Peyton M., Zou Y., Kurie J.M., Dimaio J.M., Milchgrub S., Smith A.L., Souza R.F., Gilbey L., Zhang X., Gandia K., Vaughan M.B., Wright W.E., Gazdar A.F., Shay J.W., and Minna J.D. Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Res. 64 (2004) 9027-9034
62. Scarpulla R.C. Nuclear control of respiratory gene expression in mammalian cells. J. Cell. Biochem. 97 (2006) 673-683
63. Schlegel A., Wang C., Katzenellenbogen B.S., Pestell R.G., and Lisanti M.P. Caveolin-1 potentiates estrogen receptor alpha (eralpha) signalling. Caveolin-1 drives ligand-independent nuclear translocation and activation of eralpha. J. Biol. Chem. 274 (1999) 33551-33556
64. Schwartz A.G., Prysak G.M., Murphy V., Lonardo F., Pass H., Schwartz J., and Brooks S. Nuclear estrogen receptor {beta} in lung cancer: expression and survival differences by sex. Clin. Cancer Res. 11 (2005) 7280-7287
65. Schwartz A.G., Wenzlaff A.S., Prysak G.M., Murphy V., Cote M.L., Brooks S.C., Skafar D.F., and Lonardo F. Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women. J. Clin. Oncol. 25 (2007) 5785-5792
66. Shen J., Liu J., Xie Y., Diwan B.A., and Waalkes M.P. Fetal onset of aberrant gene expression relevant to pulmonary carcinogenesis in lung adenocarcinoma development induced by in utero arsenic exposure. Toxicol. Sci. 95 (2007) 313-320
67. Silverman E.K., Weiss S.T., Drazen J.M., Chapman H.A., Carey V., Campbell E.J., Denish P., Silverman R.A., Celedon J.C., Reilly J.J., Ginns L.C., and Speizer F.E. Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 162 (2000) 2152-2158
68. Solakidi S., Psarra A.-M.G., Nikolaropoulos S., and Sekeris C.E. Estrogen receptors {alpha} and {beta} (er{alpha} and er{beta}) and androgen receptor (ar) in human sperm: localization of er{beta} and ar in mitochondria of the midpiece. Hum. Reprod. 20 (2005) 3481-3487
69. Stabile L.P., Davis A.L., Gubish C.T., Hopkins T.M., Luketich J.D., Christie N., Finkelstein S., and Siegfried J.M. Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Cancer Res. 62 (2002) 2141-2150
70. Stabile L.P., Lyker J.S., Gubish C.T., Zhang W., Grandis J.R., and Siegfried J.M. Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects. Cancer Res. 65 (2005) 1459-1470
71. Stendahl M., Kronblad A., Ryden L., Emdin S., Bengtsson N.O., and Landberg G. Cyclin d1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients. Br. J. Cancer 90 (2004) 1942-1948
72. Tyulmenkov V.T., Jernigan S.C., and Klinge C.M. Comparison of transcriptional synergy of estrogen receptors alpha and beta from multiple tandem estrogen response elements. Mol. Cell. Endocrinol. 165 (2000) 151-161
73. Tzukerman M.T., Esty A., Santiso-Mere D., Danielian P., Parker M., Stein R.B., Pike J.W., and McDonnell D.P. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol. Endocrinol. 8 (1994) 21-30
74. Watts C.K., Sweeney K.J., Warlters A., Musgrove E.A., and Sutherland R.L. Antiestrogen regulation of cell cycle progression and cyclin d1 gene expression in mcf-7 human breast cancer cells. Breast Cancer Res. Treat 31 (1994) 95-105
75. Weinberg O.K., Marquez-Garban D.C., Fishbein M.C., Goodglick L., Garban H.J., Dubinett S.M., and Pietras R.J. Aromatase inhibitors in human lung cancer therapy. Cancer Res. 65 (2005) 11287-11291
76. Yang S.-H., Liu R., Perez E.J., Wen Y., Stevens Jr. S.M., Valencia T., Brun-Zinkernagel A.-M., Prokai L., Will Y., Dykens J., Koulen P., and Simpkins J.W. Mitochondrial localization of estrogen receptor {beta}. PNAS 101 (2004) 4130-4135